Condition
Common Bile Duct Gall Stones
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07002619Not ApplicableRecruiting
ChOlanGiography Performed Routinely Versus Selectively During Cholecystectomy: A NAtional Registry-based Randomized Controlled Trial
NCT01678391Not ApplicableCompletedPrimary
Feasibility of Endoscopic Ultrasound Based Biliary Stone Removal Without Fluoroscopy
NCT02329977CompletedPrimary
Rate of Duodenal-biliary Reflux Increases in Patients With Recurrent Common Bile Duct Stones
NCT02545153Phase 2UnknownPrimary
Fibrin Sealant for Cholangiotomy Closure Study
Showing all 4 trials